# Nitrous Oxide for the Treatment of Major Depressive Disorder

> **NCT03869736** · PHASE2 · COMPLETED · sponsor: **Bayside Health** · enrollment: 81 (actual)

## Conditions studied

- Depression
- Major Depressive Disorder

## Interventions

- **DRUG:** Nitrous Oxide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03869736
- **Lead sponsor:** Bayside Health
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-22
- **Primary completion:** 2023-06-10
- **Final completion:** 2023-12-10
- **Target enrollment:** 81 (ACTUAL)
- **Last updated:** 2024-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03869736

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03869736, "Nitrous Oxide for the Treatment of Major Depressive Disorder". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03869736. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*